Galway medtech start-up Bluedrop Medical has fended off legal action taken by one of its American competitors and is now preparing a deeper push into the US market. Bluedrop, which develops a device for identifying diabetic foot ulcers, was sued earlier this year by rival Podimetrics. The US company had alleged the Irish company was infringing several of its patents in its device, which monitors a diabetic patient’s foot for ulcers. The case was dismissed at the end of October after the case and all its claims were pulled by Podimetrics. Bluedrop chief executive Chris Murphy told The Currency that…

Want to continue reading?

Celebrate with us – 7 years of The Currency

Unlock full access to The Currency and The Wall Street Journal with an annual membership and receive a FREE Samsonite Spectrolite Briefcase – worth €175 delivered to your door.

Subscribe

Cancel at any time.

Are you already a member? .